Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study.

Ili Margalit,Giusy Tiseo,Marco Ripa,Vanni Borghi,Hefziba Green,Virginie Prendki,Niccolò Riccardi,Giovanni Battista Perego,Alessandro Grembiale,Laura Galli,Marco Tinelli,Antonella Castagna,Cristina Mussini,Marco Falcone,Dafna Yahav

The Journal of antimicrobial chemotherapy（2023）

引用 0|浏览18

暂无评分

摘要

Among elderly individuals hospitalized with COVID-19, remdesivir carries survival benefit for those with moderate to severe disease. Its role among individuals with critical illness should be further assessed.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要